Literature DB >> 8790556

The molecular pathogenesis of hepatocellular carcinoma.

D Moradpour1, J R Wands.   

Abstract

Some of the multiple factors involved in the molecular pathogenesis of hepatocellular carcinoma have been elucidated in recent years but no clear picture of how and in what sequence these factors interact at the molecular level has emerged yet. Transformation of hepatocytes to the malignant phenotype may occur irrespective of the aetiological agent through a pathway of chronic liver injury, regeneration and cirrhosis. The activation of cellular oncogenes, the inactivation of tumour suppressor genes and overexpression of certain growth factors contribute to the development of HCC. There is increasing evidence that the hepatitis B virus may play a direct role in the molecular pathogenesis of HCC. Aflatoxins have been shown to induce specific mutations of the p53 tumour suppressor gene thus providing a clue to how an environmental factor may contribute to tumour development at the molecular level.

Entities:  

Mesh:

Year:  1994        PMID: 8790556     DOI: 10.1111/j.1365-2893.1994.tb00058.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  7 in total

1.  Gene expression of IQGAPs and Ras families in an experimental mouse model for hepatocellular carcinoma: a mechanistic study of cancer progression.

Authors:  Khairy M A Zoheir; Ahmed A Abd-Rabou; Gamaleldin I Harisa; Abdelkader E Ashour; Sheikh Fayaz Ahmad; Sabry M Attia; Saleh A Bakheet; Hala E Abdel-Hamied; Adel R Abd-Allah; Ashok Kumar
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population.

Authors:  G H Haydon; L M Jarvis; P Simmonds; D J Harrison; O J Garden; P C Hayes
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

3.  High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients.

Authors:  Mu-Yan Cai; Jing-Hui Hou; Hui-Lan Rao; Rong-Zhen Luo; Mei Li; Xiao-Qing Pei; Marie C Lin; Xin-Yuan Guan; Hsiang-Fu Kung; Yi-Xin Zeng; Dan Xie
Journal:  Mol Med       Date:  2010-09-10       Impact factor: 6.354

4.  Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience.

Authors:  Muhammad Idrees; Shazia Rafique; Irshadur Rehman; Haji Akbar; Muhammad-Zubair Yousaf; Sadia Butt; Zunaira Awan; Sobia Manzoor; Madiha Akram; Mahwish Aftab; Bushra Khubaib; Sheikh Riazuddin
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

5.  Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment.

Authors:  Ka-Shing Cheung; Wai-Kay Seto; Danny Ka-Ho Wong; Lung-Yi Mak; Ching-Lung Lai; Man-Fung Yuen
Journal:  Oncotarget       Date:  2017-07-18

6.  Decreased expression of PTPN12 correlates with tumor recurrence and poor survival of patients with hepatocellular carcinoma.

Authors:  Rong-Zhen Luo; Pei-Qiang Cai; Mei Li; Jia Fu; Zhi-Yi Zhang; Jie-Wei Chen; Yun Cao; Jing-Ping Yun; Dan Xie; Mu-Yan Cai
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

7.  Hepatocellular carcinoma: clinicopathological profile and challenges of management in a resource-limited setting.

Authors:  Hyasinta Jaka; Stephen E Mshana; Peter F Rambau; Nestory Masalu; Phillipo L Chalya; Samuel E Kalluvya
Journal:  World J Surg Oncol       Date:  2014-08-02       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.